API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Caffeine Pellets are formulated as modified-release or sustained-release pellets containing caffeine, an alkaloid belonging to the methylxanthine class. They are widely used for their central nervous system (CNS) stimulant effect, improving alertness, reducing fatigue, and enhancing mental performance.
| Component | Function |
|---|---|
| Caffeine | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Eudragit RS / Eudragit RL | Controlled release polymer |
| Triethyl Citrate / PEG 6000 | Plasticizer (for coating) |
| Talc | Anti-sticking agent in coating |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Caffeine Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Pellet-based formulations offer better dispersion in the GI tract, ensuring uniform absorption and reduced peak concentration spikes compared to single-unit dosage forms.
The MOQ depends on the product type and packaging, but Salius Pharma usually caters to both bulk orders and custom quantities for formulation development.
Products are packed in airtight, moisture-proof HDPE drums with double liners, ensuring stability during long transit and varying climatic conditions.
Yes, CTD / ACTD dossiers, stability data, and product specifications can be provided to facilitate regulatory approvals in the importing country.